Multivariate analysis of prognosis for patients with natural killer/T cell lymphoma-associated hemophagocytic lymphohistiocytosis.

about

Prognostic Factors of Death in 151 Adults With Hemophagocytic Syndrome: Etiopathogenically Driven Analysis

P2860

Q58804361-8C392696-7812-4037-9E3A-FCD84250B579

P2860

Multivariate analysis of prognosis for patients with natural killer/T cell lymphoma-associated hemophagocytic lymphohistiocytosis.

Item

http://www.wikidata.org/entity/Q41923461

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Multivariate analysis of progn ...... hagocytic lymphohistiocytosis.

@en

type

Item

label

Multivariate analysis of progn ...... hagocytic lymphohistiocytosis.

@en

prefLabel

Multivariate analysis of progn ...... hagocytic lymphohistiocytosis.

@en

P1476

Multivariate analysis of progn ...... hagocytic lymphohistiocytosis.

@en

P2093

Jingshi Wang

http://www.w3.org/2001/XMLSchema#string

Lin Wu

http://www.w3.org/2001/XMLSchema#string

Ruijun Pei

http://www.w3.org/2001/XMLSchema#string

Wenyuan Lai

http://www.w3.org/2001/XMLSchema#string

Yini Wang

http://www.w3.org/2001/XMLSchema#string

Zhao Wang

http://www.w3.org/2001/XMLSchema#string

Zhili Jin

http://www.w3.org/2001/XMLSchema#string

P2860

How I treat NK/T-cell lymphomas.

Hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis: a journey of a thousand miles begins with a single (big) step

Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis

Hemophagocytic Syndrome and Critical Illness: New Insights into Diagnosis and Management.

HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.

Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol

Multicenter study of combination DEP regimen as a salvage therapy for adult refractory hemophagocytic lymphohistiocytosis.

The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens.

PEG-aspargase and DEP regimen combination therapy for refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.

P304

1-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10245332.2017.1385191

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28982299

http://www.w3.org/2001/XMLSchema#string

Multivariate analysis of prognosis for patients with natural killer/T cell lymphoma-associated hemophagocytic lymphohistiocytosis.

about

P2860

P2860

Multivariate analysis of prognosis for patients with natural killer/T cell lymphoma-associated hemophagocytic lymphohistiocytosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P577

P698